Stocks-CODX-Co-Diagnostics Inc

CODX Co-Diagnostics Inc

3.15 0 (0%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest
0% Past Week
Market Cap
97.39M
Day’s Range
3.09
-
3.23
52W Range
2.24
-
7.30
Volume (3M)
146.79K
Price-Earnings Ratio
6.83
Revenue
53.22M

Co-Diagnostics Inc Latest News

View All
Pinned Post
eToro Team
🎉 Here’s a little preview introducing 16 YEARS of INVESTING on eToro 😏🤑 With love, - The eToro Team youtu.be/UFYvpJxh2qA
Like CommentShare
Show more comments2 of 57
1 reply
null
.
Top Discussions

About Co-Diagnostics Inc

Co-Diagnostics Inc is an American biotechnology company primarily involved in the development, manufacture, and sale of molecular diagnostics technology. Operating internationally, the firm focuses on providing simple, fast, and accurate diagnostic tests for a range of diseases, relying on cutting-edge technology for enhanced detection of genetic material. The firm was founded in 2013 and is based in Salt Lake City, Utah. The company’s range of Logix SmartTM kits are used to detect mycobacteria tuberculosis (MTB), Zika virus, ZDC, COVID-19, and SARS-CoV-2. The firm is also involved in the development of vector control solutions, creating diagnostic tests that can be used to test populations of mosquitos and other organisms known to act as vectors in the spread of infectious diseases. In addition, Co-Diagnostics Inc is involved in testing programmes in agriculture, primarily in the genetic enhancement of agricultural products to ensure safe but productive crops worldwide. As well as its Salt Lake City headquarters, the firm has a facility located in Gujarat, India. The CoSara Clinical Laboratories facility is situated within the Ambalal Sarabhai Foundation, with the intention to expand research and development and manufacturing activities, as well as offering clinical services. Co-Diagnostics Inc is listed on the NASDAQ under the ticker CODX. Consider adding CODX stock to your eToro watchlist.
101
Employees
Salt Lake City, Utah, US
HQ
2013
Founded
Dwight Howard Egan
CEO
Show More

Upcoming Earnings

23
MAR
REPORTS
Co-Diagnostics Inc Q4 2022 earnings report is expected to be released after market open

People Also Bought